Adjuvant HoldingsLtd Valuation
Is 4929 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 4929 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4929 (¥823) is trading below our estimate of fair value (¥11329.27)
Significantly Below Fair Value: 4929 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4929?
Key metric: As 4929 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 4929's PE Ratio? | |
|---|---|
| PE Ratio | 111.8x |
| Earnings | JP¥59.00m |
| Market Cap | JP¥6.59b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.1x |
| Enterprise Value/EBITDA | 16.1x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 4929's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 27.6x | ||
7819 SHOBIDO | 8.6x | n/a | JP¥6.7b |
4932 Almado | 29.4x | n/a | JP¥9.4b |
4524 Morishita Jintan | 21.2x | n/a | JP¥8.6b |
5194 Sagami Rubber Industries | 51.2x | n/a | JP¥11.3b |
4929 Adjuvant HoldingsLtd | 111.8x | n/a | JP¥6.6b |
Price-To-Earnings vs Peers: 4929 is expensive based on its Price-To-Earnings Ratio (111.8x) compared to the peer average (27.8x).
Price to Earnings Ratio vs Industry
How does 4929's PE Ratio compare vs other companies in the JP Personal Products Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 4929 is expensive based on its Price-To-Earnings Ratio (111.8x) compared to the JP Personal Products industry average (26.5x).
Price to Earnings Ratio vs Fair Ratio
What is 4929's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 111.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4929's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Kitanotatsujin
JP¥21.0b
Plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan.
2930
JP¥151.00
7D
-3.8%
1Y
-24.5%
Noevir Holdings
JP¥170.4b
Develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada.
4928
JP¥4,950.00
7D
-0.5%
1Y
-4.3%
SHOBIDO
JP¥6.7b
Engages in the planning, manufacturing, and selling cosmetic products in Japan and internationally.
7819
JP¥506.00
7D
-2.9%
1Y
-15.8%